State Ledger
Company profile

XBiotech Inc. CIK 1626878

Ticker
XBIT (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Austin, TX 78744
Fiscal year end
2025 (FY)
Market Data
Close
$2.22
Change
-$0.07
Change %
-2.84%
Volume
1,184

XBIT · trading date Oct 13, 2026 · previous close $2.29 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$45.54M
Total assets
$150.08M
Total liabilities
$9.73M
Stockholders' equity
$140.35M
Cash & equivalents
$125.55M
Operating income
-$55.69M
Operating cash flow
-$39.92M
Capital expenditures
$289.0K

Fiscal year 2025, via 10-K filed 2026-03-13. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$40.21M
Free cash flow margin
—
Liabilities / assets
6.5%
Equity / assets
93.5%
CapEx / revenue
—
Operating cash flow / net income
0.88×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$45.54M $150.08M $9.73M $140.35M
2024 — -$38.53M $199.09M $16.83M $182.27M
2023 — -$24.56M $226.62M $7.77M $218.85M
2022 — -$32.90M $246.10M $5.70M $240.40M
2021 — -$17.41M $275.18M $5.79M $269.39M
Company Details
SIC code
2834
State of incorporation
A1
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-13
Financials filed via
Form 10-K
filed 2026-03-13

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Austin, TX 78744
5217 WINNEBAGO LANE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:57 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Texas — Public Companies